Data / Form D filings / CHIASMA, INC
CHIASMA, INC: Form D filings
CHIASMA, INC, a biotechnology company in Newton Centre, MA, filed 10 Form D notices with the SEC between 2009 and 2015. The latest, on March 5, 2015, reports $69.7 million sold of a $87.2 million offering to 21 investors.
Find out what CHIASMA, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 831 BEACON STREET, SUITE 313, Newton Centre, MA, 02459
- Phone
- (866) 637-9703
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1339469
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2015 | Amendment | $87,153,480 | $69,722,786 | $17,430,694 | 21 | Dec 16, 2014 | sec.gov |
| Dec 24, 2014 | New notice | $56,250,000 | $33,774,763 | $22,475,237 | 11 | Dec 16, 2014 | sec.gov |
| Jul 23, 2012 | New notice | $38,659,507 | $10,026,669 | $28,632,838 | 10 | Jul 11, 2012 | sec.gov |
| Jun 7, 2012 | New notice | $3,038,335 | $3,038,335 | $0 | 8 | Jun 1, 2012 | sec.gov |
| Jul 1, 2011 | New notice | $23,350,000 | $5,115,000 | $18,235,000 | 10 | Jun 24, 2011 | sec.gov |
| Jun 14, 2011 | Amendment | $10,000,000 | $10,000,000 | $0 | 8 | Jul 20, 2010 | sec.gov |
| Mar 9, 2011 | Amendment | $9,000,000 | $9,000,000 | $0 | 7 | Jul 20, 2010 | sec.gov |
| Jan 6, 2011 | Amendment | $6,000,000 | $5,000,000 | $1,000,000 | 7 | Jul 20, 2010 | sec.gov |
| Jul 22, 2010 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 7 | Jul 20, 2010 | sec.gov |
| Nov 24, 2009 | New notice | $4,800,000 | $2,800,000 | $2,000,000 | 6 | Nov 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott J. Minick | Director | |
| John A. Scarlett | Director | |
| Chaime K. Orlev | Executive Officer | |
| Todd T. Foley | Director | |
| Vincent J. Miles | Director | |
| Ansbert K. Gadicke | Director | |
| Roni Mamluk | Executive Officer, Director | |
| Dror Brandwein | Director | |
| Bard J. Geesaman | Director | |
| David M. Stack | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Mar 2, 2015 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CHIASMA, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.